The effect of cumulative energy in repeated subliminal transscleral cyclophotocoagulation a retrospective study /

The long-term safety and efficacy of repeated applications of subliminal transscleral cyclophotocoagulation (SL-TSCPC) with a focus on cumulative energy was evaluated in glaucoma patients.In this retrospective, multicentric study the data of a total of 82 eyes with various causes of glaucoma that we...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Szabó Áron
Árpádffy-Lovas Tamás
Hagyó Krisztina
Cseke István
Vámosi Péter
Tóth-Molnár Edit
Dokumentumtípus: Cikk
Megjelent: 2024
Sorozat:BMC OPHTHALMOLOGY 24 No. 1
Tárgyszavak:
doi:10.1186/s12886-024-03505-7

mtmt:34900561
Online Access:http://publicatio.bibl.u-szeged.hu/34816
Leíró adatok
Tartalmi kivonat:The long-term safety and efficacy of repeated applications of subliminal transscleral cyclophotocoagulation (SL-TSCPC) with a focus on cumulative energy was evaluated in glaucoma patients.In this retrospective, multicentric study the data of a total of 82 eyes with various causes of glaucoma that were treated with a single or multiple applications of SL-TSCPC were collected. Treatments were performed under general or local anesthesia with an 810 nm diode laser. Power was 2000 mW; duty cycle, 31.3%; total treatment duration, 80-320 s; equaling a total energy of 50-200 J per treatment session. Fifty-five eyes (55 patients) presented for all follow-ups, and these eyes were selected for further statistical analysis. The mean age was 60.0 ± 17.1 years, and 22 (40%) of the patients were female. Intraocular pressure (IOP) and dependence on further glaucoma medication were evaluated at 12 months following the initial treatment.Eyes underwent 1 or 2 consecutive SL-TSCPC treatments. Median (min-max) baseline IOP of 34 (13-69) decreased to 21.5 (7-61), 22 (8-68), 20 (9-68), and 19.5 (3-60) mmHg at the 1, 3, 6, and 12-month postoperative timepoints respectively. The mean (± SD) IOP decrease at 12 months was 26 ± 27%, 39 ± 32%, and 49 ± 33% in the low (below 120 J, n = 18), medium (120-200 J, n = 24), and high (above 200 J, n = 13) cumulative energy groups respectively. At the 12-month timepoint, oral carbonic anhydrase use was discontinued in ¾ of the cases.It was found that the repeated application of SL-TSCPC safely and efficiently decreases IOP in a Caucasian population with heterogenous causes of glaucoma, eyes with silicone oil responded to a greater extent. Inclusion of cumulative energy scales may contribute to better addressing repeated procedures in a standardized fashion.
Terjedelem/Fizikai jellemzők:10
ISSN:1471-2415